Cost-effectiveness of strategies for testing current hepatitis C virus infection.

Chapko, Michael K; Dufour, D Robert; Hatia, Rikita I; Drobeniuc, Jan; Ward, John W; Teo, Chong-Gee

Chapko, Michael K; Dufour, D Robert; Hatia, Rikita I; Drobeniuc, Jan; Ward, John W; Teo, Chong-Gee.

Afiliación

Chapko MK; Veterans Affairs Paget Sound Health Care System and University of Washington, Seattle, WA.
Dufour DR; Veterans Affairs Medical Center, Washington, DC.
Hatia RI; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA.
Drobeniuc J; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA.
Ward JW; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA.
Teo CG; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA.

Hepatology ; 62(5): 1396-404, 2015 Nov.

Article en En | MEDLINE | ID: mdl-26126725

Asunto(s)

Análisis Costo-Beneficio; Hepatitis C/diagnóstico; Anticuerpos contra la Hepatitis C/sangre; Humanos; Sistemas de Atención de Punto; ARN Viral/sangre

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_financiamento_saude Asunto principal: Análisis Costo-Beneficio / Hepatitis C Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Hepatology Año: 2015 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google